by John A. Jenkins | Aug 5, 2026 | FDA, FOIA, Hedge Funds, Pharmaceuticals, Stock Market
FOIAengine: Requests from Point72, Sofinnova, Holocene, Triple Gate and Others A review of the latest Freedom of Information Act requests targeting three life-sciences companies – Novo Nordisk (NYSE: NVO); Charles River Laboratories (NYSE: CRL); and iRhythm...
by John A. Jenkins | Jul 30, 2026 | FDA, FOIA, News Media, Pharmaceuticals, Politics
FOIAengine: Multiple News Outlets Sought Details on “Compassionate Use” Within days of a Stat News report describing a highly unusual government decision to grant a 79-year-old patient early access to Eli Lilly’s experimental obesity drug retatrutide, some of the...
by John A. Jenkins | Jul 16, 2026 | FOIA, Politics
FOIAengine: How the GOP’s Senate Campaign Committee Plays the Oppo Game While national reporters were examining Graham Platner’s turbulent personal life, Republican opposition researchers were quietly investigating an entirely different chapter of the Maine Senate...
by John A. Jenkins | Jun 17, 2026 | FOIA, Hedge Funds, SEC, Short-Selling, Stock Market
FOIA Requests Offer Signals, and a Requester Provides Names Activist short seller Andrew Left always had a taste for risk. So, with his freedom and fortune on the line a few weeks ago in a Los Angeles courtroom, Left tried to beat the federal securities fraud charges...
by John A. Jenkins | Jun 4, 2026 | CFTC, Cryptocurrency, FOIA, News Media, Politics
FOIAengine: Requests Pile Up, As State and Federal Lawmakers Square Off Months before the regulatory chaos around prediction markets exploded into courtrooms, state houses, and the White House, sophisticated observers were already paying attention. More than 170...
